Apogee Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Apogee Therapeutics, Inc. (APGE) reported Capital Expenditures Incurred but Not yet Paid of $229.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-11
- Apogee Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $229.00K.
- Apogee Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $0.00.
- Apogee Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $619.00K, a 194.76% increase from fiscal 2023.
- Apogee Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $210.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|
| 2025-03-31 | $229.00K 10-Q · filed 2026-05-11 | |
| 2024-12-31 | $619.00K 10-K · filed 2026-03-02 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $210.00K 10-K · filed 2026-03-02 |